Skip to main content
. 2017 Feb 7;14(2):115–122. doi: 10.7150/ijms.17227

Table 1.

Demographic data.

Control (N = 36) RIPC (N = 36) P
Gender 0.199
Male 31 (47.0%) 35 (53.0 %)
Female 5 (83.3%) 1 (16.7%)
Age (years) 71.4 ± 7.2 69.1 ± 6.6 0.163
Height (cm) 152.0 (148.5-157.4) 150.9 (148.0-158.0) 0.991
Weight (kg) 61.1 (54.5-67.6) 56.5 (51.2-62.1) 0.075
Smoking history 3 (75.0%) 1 (25.0%) 0.614
Operation site 0.810
Left 22 (51.2%) 21 (48.8%)
Right 14 (48.3%) 15 (51.7%)
Underlying diseases
HTN 21 (53.8%) 18 (46.2%) 0.478
DM 11 (52.4%) 10 (47.6%) 0.795
Anaesthetic agents
Sevofluranemin (Vol%) 1.0 (1.0-1.2) 1.1 (1.0-1.3) 0.185
Sevofluranemax (Vol%) 2.0 (1.8-2.0) 1.8 (1.5-2.0) 0.217
Remifentanil (μg) 1408.0 (1254.0-1755.5) 1431.0 (1276.0-1667.0) 0.973
Vasopressor or inotropics
Phenylephrine (μg) 372.5 (95.0-907.5) 172.5 (15.0-710.0) 0.153
Ephedrine (mg) 0.0 (0.0-0.0) 0.0 (0.0-4.0) 0.365
Incidence of atropine 4 (11.1%) 6 (16.7%) 0.733
Anaesthesia duration (min) 0.727
169.5 (153.0-192.5) 173.5 (157.5-190.0)
Operation duration (min) 0.933
107.0 (97.0-130.0) 113.0 (100.0-130.0)
Tourniquet duration (min) 0.000
0.0 (0.0-0.0) 300.0 (280.0-300.0)
Transfusion and bleeding
Intraoperative pRBC transfusion (units) 0.043
0 25 (42.4%) 34 (57.6%)
1 3 (100.0%) 0 (0.0%)
2 7 (77.8%) 2 (22.2%)
4 1 (100.0%) 0 (0.0%)
Postoperative pRBC transfusion (units) 0.002
0 25 (41.0%) 36 (59.0%)
1 1 (100.0%) 0 (0.0%)
2 10 (100.0%) 0 (0.0%)
Postoperative 24 h bleeding (mL) 0.000
365.3 ± 192.2 193.4 ± 146.1

Values are expressed as the number of patients or mean ± standard deviation or median (25% -75%).

Abbreviations: Control, control group; RIPC, remote ischaemic preconditioning group; HTN, hypertension; DM, diabetes mellitus; Sevofluranemin, consumed minimal concentration of sevoflurane during anaesthesia; Sevofluranemax, consumed maximal concentration of sevoflurane during anaesthesia; pRBC, packed red blood cell.